Parsabiv Unión Europea - español - EMA (European Medicines Agency)

parsabiv

amgen europe b.v. - etelcalcetide hydrochloride - hiperparatiroidismo, secundario - anti-parathyroid agents, calcium homeostasis - parsabiv está indicado para el tratamiento del hiperparatiroidismo secundario (shpt) en pacientes adultos con enfermedad renal crónica (erc) en terapia de hemodiálisis.

Libmeldy Unión Europea - español - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - otras drogas del sistema nervioso - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

SOLARSAL 0,05 % SOLUCION ATOMIZADOR NASAL Venezuela - español - Instituto Nacional de Higiene

solarsal 0,05 % solucion atomizador nasal

biotech laboratorios, c.a. - oximetazolina clorhidrato - solucion - 0,05 %

SOLARSAL 0,025 % SOLUCION NASAL Venezuela - español - Instituto Nacional de Higiene

solarsal 0,025 % solucion nasal

biotech laboratorios, c.a. - oximetazolina clorhidrato - solucion - 0,025 %